Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial

Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-06-12T15:32:27.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page has updated its references to Biogen, indicating a shift in the ownership structure of Reata Pharmaceuticals. Additionally, several future dates have been added, while previous dates have been removed.
    Difference
    3%
    Check dated 2025-06-05T11:13:48.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T05:56:07.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-05-22T02:32:45.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-05-07T19:24:28.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.6%
    Check dated 2025-04-30T13:58:21.000Z thumbnail image

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.